| Name | LRRK2-IN-10 |
|---|---|
| Synonyms |
RK2-IN-10
1H-Indene-5-carbonitrile, 2,3-dihydro-1-[[3-(4-isoxazolyl)-1H-indazol-5-yl]amino]-, (1S) |
| Description | LRRK2-IN-10 (compound 34) is a potent, mutation-selective, and brain penetrant G2019S-LRRK2 kinase inhibitor with IC50s of 11 nM and 5.2 nM for G2019S-LRRK2 pS935 and G2019S-LRRK2 pS1292, respectively. LRRK2-IN-10 has the potential for Parkinson's disease research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C20H15N5O |
|---|---|
| Molecular Weight | 341.37 |